Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Hair loss in women linked to higher sexual dysfunction risk.

Early hair loss may indicate future prostate issues.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Finasteride has different absorption and metabolism in male and female rats, with higher concentrations in certain organs and mostly excreted through feces.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.